Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jun 16, 2011

Premium

Alnylam Pharmaceuticals has appointed Akshay Vaishnaw to the newly created position of chief medical officer.

Vaishnaw was previously senior vice president of clinical research at Alnylam. Before that, he was senior director of translational medicine at Biogen Idec.


Mirna Therapeutics has appointed Art Krieg as a scientific advisor.

Krieg is currently an entrepreneur in residence at venture capital firm Atlas Ventures. Before this, he served as CSO of Pfizer's oligonucleotide therapeutics unit, which was recently shut down as part of a corporate restructuring.

He was also the CSO and co-founder of Coley Pharmaceuticals, which was acquired by Pfizer in 2008.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.